X. Shang

Chemical Modification of Cysteine Mutants of Subtilisin Bacillus lentus Can Create Better Catalysts Than the Wild-Type Enzyme

J. B. Jones, C. Mitchinson, Per Berglund, 1997 .

A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.

J. Therrien, W. Baker, R. Shawar, 2004, Journal of medicinal chemistry.

Toward tailoring the specificity of the S1 pocket of subtilisin B. lentus: chemical modification of mutant enzymes as a strategy for removing specificity limitations.

J. B. Jones, G. Desantis, X. Shang, 1999, Biochemistry.

The controlled introduction of multiple negative charge at single amino acid sites in subtilisin Bacillus lentus.

J. B. Jones, B. G. Davis, G. Desantis, 1999, Bioorganic & medicinal chemistry.